Previous 10 | Next 10 |
RICHMOND, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that management will participate in a fireside chat at the H.C. Wainwright 23 rd Annual Global In...
Ekso Bionics Holdings, Inc. (EKSO) Q2 2021 Results Conference Call July 29, 2021 4:30 PM ET Company Participants Matt Steinberg - Investor Relations-Lazar Finn Partners Jack Peurach - President and CEO Jack Glenn - Chief Financial Officer Bill Shaw - Chief Commercial Officer Conference Call P...
Ekso Bionics Holdings (NASDAQ:EKSO): Q2 GAAP EPS of $0.11 beats by $0.36. Revenue of $2.2M (-2.7% Y/Y) beats by $0.06M. Gross margins of ~58%, compared with gross margin of 56% for the same period in 2020. Press Release For further details see: Ekso Bionics Holdings EPS beats by $0.36, ...
RICHMOND, Calif., July 29, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended June 30, 2021. Recent ...
RICHMOND, Calif., July 22, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2021 after the close of tra...
Ekso Bionics was able to raise new equity at attractive terms during Q1, putting it in net cash positive position around $45 million heading into the second half of 2021. The company is moving ahead with a subscription model for both its EksoHealth (stroke rehab exosuits) and EksoWork...
Gainers: Fluidigm (FLDM) +14%, ShockWave Medical (SWAV) +14%, Precision BioSciences (DTIL) +10%, Ekso Bionics (EKSO) +9%, Cerecor (CERC) +5%.Losers: Larimar Therapeutics (LRMR) -20%, Nano-X Imaging (NNOX) -17%, PMV Pharmaceuticals (P...
Ekso Bionics Holdings shares jump ([[EKSO]] +12.6%) after expanding its partnership with Kindred Healthcare bringing EksoNR robotic exoskeleton to four of Kindred’s Long-Term Acute Care (“LTAC”) Hospitals in the U.S.The multi-unit order follows a successful pilot pro...
Following Successful Pilot Program, EksoNR will be Available at Four of Kindred’s Long-Term Acute Care Hospitals in Florida RICHMOND, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exo...
Ekso Bionics Holdings, Inc. (EKSO) Q1 2021 Earnings Conference Call April 29, 2021 4:30 p.m. ET Company Participants Matt Steinberg - Investor Relations-Lazar Finn Partners Jack Peurach - President and CEO Jack Glenn - CFO Bill Shaw - Chief Commercial Officer Conference Call Participants RK -...
News, Short Squeeze, Breakout and More Instantly...
Ekso Bionics Holdings Inc. Company Name:
EKSO Stock Symbol:
NASDAQ Market:
Ekso Bionics Holdings Inc. Website:
SAN RAFAEL, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2...
Collaboration Expands Use of EksoNR and Ekso Indego Devices in Rehabilitation and Community Settings to Better Improve Patient Quality of Life SAN RAFAEL, Calif., June 25, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso...
Brings Strategic Healthcare Expertise and Extensive Experience with the U.S. Department of Veterans Affairs (VA) to Ekso’s Board Deborah Lafer Scher SAN RAFAEL, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”...